Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22082354 | 1.00 | RXFP1 (0.51) | RXFP1ELANEKMT2AMEN1BAZ1A | |
| SCHEMBL12863515 | 0.95 | RXFP1 (0.56) | RXFP1ELANEKMT2AMEN1BAZ1A | |
| SCHEMBL17084524 | 0.87 | KMT2A (0.56) | RXFP1ELANEKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL17084527 | 0.87 | KMT2A (0.56) | RXFP1ELANEKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL21350461 | 0.86 | MMP1 (0.51) | KMT2AMEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL22258851 | 0.85 | MAPT (0.53) | ELANEKMT2AMEN1SMN1; SMN2L3MBTL1 | |
| SCHEMBL17433304 | 0.85 | ELANE (0.62) | ELANEKMT2AMEN1HTTATM | |
| SCHEMBL803168 | 0.85 | ELANE (0.62) | ELANEKMT2AMEN1HTTATM | |
| SCHEMBL17084525 | 0.85 | RXFP1 (0.67) | RXFP1KMT2AMEN1BAZ1ASMN1; SMN2 | |
| SCHEMBL12872192 | 0.85 | ELANE (0.62) | ELANEKMT2AMEN1HTTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020230480-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT, AND COMPOUND | DIC株式会社 | 2020-11-19 | — | — | WO | disclosed |
| US-9983441-B2 | Liquid crystal display device | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-20160168465-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | TOYO GOSEI CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20150261044-A1 | LIQUID CRYSTAL DISPLAY DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168465-A1 | MONOMER, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND PRODUCTION METHOD FOR LIQUID CRYSTAL DISPLAY DEVICE | SP1, ZYX, NOD1 | RXFP1 600/4885ELANE 3681/4885KMT2A 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.